Who makes QFTB-G and T-SPOT.TB tests?

QFTB-G and T-SPOT.TB tests is developed by Assistance Publique - Hôpitaux de Paris.

What development phase is QFTB-G and T-SPOT.TB tests in?

QFTB-G and T-SPOT.TB tests is in Phase 1.

Last reviewed 2026-04-19 · How we verify

QFTB-G and T-SPOT.TB tests

Assistance Publique - Hôpitaux de Paris · Phase 1 active Biologic

At a glance

Generic name	QFTB-G and T-SPOT.TB tests
Also known as	There are no arms currently listed for this study.
Sponsor	Assistance Publique - Hôpitaux de Paris
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

QFTB-G and T-SPOT.TB tests CI brief — competitive landscape report
QFTB-G and T-SPOT.TB tests updates RSS · CI watch RSS
Assistance Publique - Hôpitaux de Paris portfolio CI